Genetic variant R952Q in LRP8 is associated with increased plasma triglyceride levels in patients with earlyonset CAD and MI
Some providers recommend more frequent thyroid function testing when starting injectable GLP-1 medications in patients taking levothyroxine, particularly during the first few months of treatment and after significant weight loss
Over the past decade, clinical trials have demonstrated that GLP-1R agonists significantly reduce major adverse cardiovascular events (MACEs), including myocardial infarction, stroke, and cardiovascular mortality, particularly in patients with type 2 diabetes
The votes are not binding, and the FDA will ultimately decide whether to lift current restrictions on these peptides and make them more easily accessible to people whove been turning to the little-researched but highly popular drugs to improve their health
CoolSculpting is a non surgical fat reduction treatment that can be carried out in-clinic
Consistency is Key: Regular use of semaglutide GLP-1, along with following a balanced diet and exercise routine, can help maintain long-term appetite control